Can atherogenic indices and the triglyceride-glucose index be used to predict erectile dysfunction?

ArticleAçık Erişim

Özet

Background: Atherosclerosis and insulin resistance play an important role in the development of erectile dysfunction (ED), and few studies have comprehensively evaluated more specific indicators like atherogenic indices and the triglyceride-glucose (TyG) index in the assessment of ED. Aim: This study aimed to reveal the role of atherogenic indices (atherogenic index of plasma [AIP], Castelli risk index-1/2 [CRI-1/2], and atherogenic coefficient [AC]) based on plasma lipid ratios, which have been used as more sensitive indicators of atherosclerosis in recent years, and the TyG index, a practical indicator of insulin resistance, in predicting vasculogenic ED. Methods: The study included a total of 199 patients who met the inclusion criteria and a total of 51 control subjects without ED complaints according to the International Index of Erectile Function (IIEF-5) scores (>21) between May 2021 and October 2022. For all participants, the demographic and biochemical parameters were evaluated, and atherogenic indices, namely CRI-1 (total cholesterol/high-density lipoprotein [HDL]), CRI-2 (LDL/HDL) AIP [log10(triglycerides/HDL)], and AC (non-HDL/HDL), as well as the TyG index [Ln {fasting triglycerides (mg/dL) × fasting glucose (mg/dL)/2}] were calculated. Outcomes: The TyG index, which is an indicator of insulin resistance, and atherogenic indices such as CRI-1, AIP, and AC were significantly associated with ED, and especially AIP and the TyG index seem to be more important in the evaluation of ED. Results: According to the univariate analysis, the patient group had significantly higher CRI-1 (5.3 ± 1.4 vs 4.7 ± 1.3; P = .005), AIP (0.31 ± 0.26 vs 0.13 ± 0.2; P < .001), AC (4.1 ± 1.4 vs 3.70 ± 1.2; P = .026), and TyG (9.16 ± 0.71 vs 8.77 ± 0.52; P < .001) values compared with the control group. In the correlation analysis, a significant negative correlation was found between the AIP and TyG index and the IIEF-5 scores (r2 = 0.120, P < .001 between AIP and IIEF-5; r2 = 0.091, P < .001 between TyG index and IIEF-5). The multivariate analysis revealed AIP and the TyG index as independent predictive factors for ED. Clinical Implications: The use of atherogenic indices and TyG index in daily urology practice can help physicians in the diagnosis and follow-up of ED. Strengths and Limitations: The lack of sex hormone–binding globulin and free testosterone levels represents a limitation of our study. Another limitation is that the severity of ED was determined using the IIEF-5 scores, rather than a more objective method, such as penile artery ultrasound. Conclusion: Atherogenic indices and the TyG index can be used as inexpensive and practical markers to predict the severity of arteriogenic ED. © 2023 Elsevier B.V.. All rights reserved.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/12052Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1093/sexmed/qfad069Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorSambel, Murat
dc.contributor.authorErdogan, Abdullah
dc.contributor.authorCaglayan, Volkan
dc.contributor.authorAvci, Sinan
dc.contributor.authorKilic, Sahin
dc.contributor.authorYildiz, Halil Emre
dc.contributor.authorKeskin, Ercument
dc.date.accessioned2026-10-18T20:27:00.362488927Z
dc.date.available2026-10-18T20:27:00.362488927Z
dc.date.issued2023
dc.description.abstractBackground: Atherosclerosis and insulin resistance play an important role in the development of erectile dysfunction (ED), and few studies have comprehensively evaluated more specific indicators like atherogenic indices and the triglyceride-glucose (TyG) index in the assessment of ED. Aim: This study aimed to reveal the role of atherogenic indices (atherogenic index of plasma [AIP], Castelli risk index-1/2 [CRI-1/2], and atherogenic coefficient [AC]) based on plasma lipid ratios, which have been used as more sensitive indicators of atherosclerosis in recent years, and the TyG index, a practical indicator of insulin resistance, in predicting vasculogenic ED. Methods: The study included a total of 199 patients who met the inclusion criteria and a total of 51 control subjects without ED complaints according to the International Index of Erectile Function (IIEF-5) scores (>21) between May 2021 and October 2022. For all participants, the demographic and biochemical parameters were evaluated, and atherogenic indices, namely CRI-1 (total cholesterol/high-density lipoprotein [HDL]), CRI-2 (LDL/HDL) AIP [log10(triglycerides/HDL)], and AC (non-HDL/HDL), as well as the TyG index [Ln {fasting triglycerides (mg/dL) × fasting glucose (mg/dL)/2}] were calculated. Outcomes: The TyG index, which is an indicator of insulin resistance, and atherogenic indices such as CRI-1, AIP, and AC were significantly associated with ED, and especially AIP and the TyG index seem to be more important in the evaluation of ED. Results: According to the univariate analysis, the patient group had significantly higher CRI-1 (5.3 ± 1.4 vs 4.7 ± 1.3; P = .005), AIP (0.31 ± 0.26 vs 0.13 ± 0.2; P < .001), AC (4.1 ± 1.4 vs 3.70 ± 1.2; P = .026), and TyG (9.16 ± 0.71 vs 8.77 ± 0.52; P < .001) values compared with the control group. In the correlation analysis, a significant negative correlation was found between the AIP and TyG index and the IIEF-5 scores (r2 = 0.120, P < .001 between AIP and IIEF-5; r2 = 0.091, P < .001 between TyG index and IIEF-5). The multivariate analysis revealed AIP and the TyG index as independent predictive factors for ED. Clinical Implications: The use of atherogenic indices and TyG index in daily urology practice can help physicians in the diagnosis and follow-up of ED. Strengths and Limitations: The lack of sex hormone–binding globulin and free testosterone levels represents a limitation of our study. Another limitation is that the severity of ED was determined using the IIEF-5 scores, rather than a more objective method, such as penile artery ultrasound. Conclusion: Atherogenic indices and the TyG index can be used as inexpensive and practical markers to predict the severity of arteriogenic ED. © 2023 Elsevier B.V.. All rights reserved.
dc.identifier.doi10.1093/sexmed/qfad069
dc.identifier.eissn2050-1161
dc.identifier.issn2050-1161
dc.identifier.issue6
dc.identifier.pmcidPMC10799712
dc.identifier.pmid38250336
dc.identifier.scopus2-s2.0-85196263037
dc.identifier.startpageqfad069
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/12052
dc.identifier.volume11
dc.identifier.wosWOS:001155037800002
dc.language.isoen
dc.publisherOxford University Press
dc.relation.ispartofSexual Medicine
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectatherogenic indices
dc.subjectendothelial dysfunction
dc.subjecterectile dysfunction
dc.subjectinsulin resistance
dc.subjecttriglyceride-glucose index
dc.subjectglucose
dc.subjecthigh density lipoprotein
dc.subjectlow density lipoprotein
dc.subjectsex hormone binding globulin
dc.subjecttestosterone
dc.subjecttriacylglycerol
dc.subjectadult
dc.subjectArticle
dc.subjectatherogenic index
dc.subjectcholesterol blood level
dc.subjectcomparative study
dc.subjectcontrolled study
dc.subjectcorrelation analysis
dc.subjectcross-sectional study
dc.subjectfollow up
dc.subjecthuman
dc.subjectInternational Index of Erectile Function
dc.subjectlipid blood level
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmiddle aged
dc.subjectpenis artery
dc.titleCan atherogenic indices and the triglyceride-glucose index be used to predict erectile dysfunction?
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus10
rdl.citation.wos9
rdl.departmentDepartment of Urology, Mengucek Gazi Education and Research Hospital, Erzincan Binali Yildirim University, 24002, Erzincan, Turkey.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)